Nasdaq to Delist Glucotrack After Listing-Rule Exception Failure
Nasdaq notified Glucotrack on October 28 that its securities would be delisted after the closing bid price fell to $0.87 on October 14, failing the terms of an exception to Nasdaq Listing Rule 5550(a)(2). Trading is scheduled to be suspended at the open on October 30, 2026.
On October 28, 2026, Nasdaq notified Glucotrack that it would delist the company’s securities after the closing bid price fell to $0.87 on October 14, failing the terms of an exception to Nasdaq Listing Rule 5550(a)(2). Trading is scheduled to be suspended at the open on October 30, 2026; the compa…